Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dioralyte oral powder sachets blackcurrant
0902012H0BBAGAE
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | 29,263 |
|
Dioralyte oral powder sachets plain
0902012H0BBAEAE
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | 12,590 |
|
Dioralyte oral powder sachets citrus
0902012H0BBAFAE
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | 5,978 |
|
Dioralyte Relief oral powder sachets blackcurrant
0902012H0BBALAJ
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | 1,927 |
|
O.R.S Oral Rehydration Salts ORS soluble tab blackcurrant
0902012H0BWABAN
|
O.R.S (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 1,319 |
|
Dioralyte Relief oral powder sachets raspberry
0902012H0BBAKAJ
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | 640 |
|
O.R.S Oral Rehydration Salts ORS soluble tablets lemon
0902012H0BWAAAN
|
O.R.S (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 433 |
|
O.R.S Oral Rehydration Salts ORS soluble tablets strawberry
0902012H0BWACAN
|
O.R.S (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 412 |
|
Glucose monohydrate 20g/Sod chlor 3.5g/Sod bicarb 2.5g pdr
0902012H0AAAKAK
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 86 |
|
SOS Rehydrate oral powder sachets mixed berry
0902012H0BXAAA0
|
SOS (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 48 |
|
Generic Dioralyte oral powder sachets
0902012H0AAAEAE
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 29 |
|
Generic O.R.S Oral Rehydration Salts ORS soluble tablets
0902012H0AAANAN
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 8 |
|
SOS Rehydrate oral powder sachets lemon
0902012H0BXABA0
|
SOS (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 6 |
|
SOS Rehydrate oral powder sachets mango
0902012H0BXACA0
|
SOS (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 5 |
|
Generic Dioralyte Relief oral powder sachets sugar free
0902012H0AAAJAJ
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 3 |
|
Rehydration Treatment granules 4.87g sach (The Boots Co)
0902012H0BNABA0
|
Boots (Oral rehydration) | Oral rehydration salts | Nutrition and Blood | 3 |
|
SOS Rehydrate oral powder sachets coconut
0902012H0BXADA0
|
SOS (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 3 |
|
Electrorush ORS oral powder sachets blackcurrant
0902012H0BZACAQ
|
Electrorush | Oral rehydration salts | Nutrition and Blood | 1 |
|
Rehydration Treatment granules 4.87g sachets (E M Pharma)
0902012H0BVAAA0
|
Rehydration Treatment | Oral rehydration salts | Nutrition and Blood | 1 |
|
SOS Rehydrate oral powder sachets watermelon
0902012H0BXAEA0
|
SOS (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | 1 |
|
AACT Rehydration oral powder sachets
0902012H0CBAAAE
|
AACT | Oral rehydration salts | Nutrition and Blood | No data available |
|
Dioralyte effervescent tablets blackcurrant
0902012H0BBAIAA
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | No data available |
|
Dioralyte effervescent tablets citrus
0902012H0BBAHAA
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | No data available |
|
Dioralyte Relief oral powder sachets apricot
0902012H0BBAJAJ
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | No data available |
|
Electrolade oral powder sachets banana
0902012H0BCAAAD
|
Electrolade | Oral rehydration salts | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.